AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Scientists have developed a high-throughput method to monitor the humoral immune response against vaccinia virus.
According to published research from Germany and Sweden, "Vaccination against smallpox is again considered in order to face a possible bioterrorist threat, but the nature and the level of the immune response needed to protect a person from smallpox after vaccination are not totally understood. Therefore, simple, rapid, and accurate assays to evaluate the immune response to vaccinia virus need to be developed. Neutralization assays are usually considered good predictors of vaccine efficacy and more informative with regard to protection than binding assays."
"Currently, the presence of neutralizing antibodies to vaccinia virus is measured using a plaque reduction neutralization test, but this method is time-consuming and labor-intensive and has a subjective readout," said Antonio Cosma at the GSF-National Research Center for Environment and Health and collaborators in Germany and Sweden. "Here, we describe an innovative neutralization assay based on a modified vaccinia virus Ankara (MVA) vector expressing the green fluorescent protein (WA-gfp). This MVA-gfp neutralization assay is rapid and sensitive and has a high-throughput potential.
"Thus, it is suitable to monitor the immune response and eventually the efficacy of a large campaign of vaccination ...
Source: HighBeam Research, Method developed to monitor immune response against vaccinia virus.